| 英文别名 |
2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carbox;2-(2-aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide;4-Pyrimidinecarboxamide, 2-(1-amino-1-methylethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-;2-(1-amino-1-methyl-ethyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid 4-fluoro-benzylamide;2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxami;2-(2-aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;C16H19FN4O3;Raltegravir amine;2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihy dropyrimidine-4-carboxami;2-(1-amino-1-methyl-ethyl)-;DS-1539;AM85799;2-(2-AMINOPROPAN-2-YL)-N-((4-FLUOROPHENYL)METHYL)-5-HYDROXY-1-METHYL-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE;NS00002534;RALTEGRAVIR IMPURITY A [EP IMPURITY];UNII-5U1A5S652K;4-Pyrimidinecarboxamide, 2-(1-amino-1-methylethyl)-N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-;AC-1805;FT-0661911;AKOS015899148;2-(1-amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine4-carboxamide;518048-03-8;SCHEMBL1151004;DES(5-methyl-1,3,4-oxadiazole-2-carbonyl)raltegravir;MFCD10698741;A852177;AQLZTHZLYFFVIJ-UHFFFAOYSA-N;5U1A5S652K;ZB1810;J-505521;DTXSID50716265;SB57948;RALTEGRAVIR IMPURITY, RALTEGRAVIR AMINE [USP IMPURITY];BCP11621;RALTEGRAVIR POTASSIUM IMPURITY A [EP IMPURITY];CS-W000543;2-(1-AMINO-1-METHYL-ETHYL)-HYDROXY-1-METHYL-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXYLIC ACID 4-FLUORO-BENZYLAMIDE;2-(1-Amino-1-methyl-ethyl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-pyrimidine-4-carboxamide |